Last news
BIGBIG WON Unveils New Switch, PC Controllers at CES 2023

BIGBIG WON Unveils New Switch, PC Controllers at CES 2023

...

Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

...

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

...

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

...

Innovent Announces NMPA's Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer

Innovent Announces NMPA's Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer

...

DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference

DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference

...

Hisense CES 2023: Expanding Global Footprint and Paving the Way for Ongoing Growth

Hisense CES 2023: Expanding Global Footprint and Paving the Way for Ongoing Growth

...

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

...

menu
menu